Dna X (SONM) Other Non-Current Liabilities (2018 - 2026)

Dna X has reported Other Non-Current Liabilities for 9 years, with the latest figure at $398000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities fell 77.81% year-over-year to $398000.0; the trailing twelve-month figure through Mar 2026 stood at $398000.0 (down 77.81% YoY), and the FY2025 full-year result was $171000.0, down 89.94% from the prior year.
• Other Non-Current Liabilities for Q1 2026 stood at $398000.0, up from $171000.0 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $1.8 million in Q3 2025, with the low at $171000.0 in Q4 2025.
• Historically, Other Non-Current Liabilities has averaged $1.4 million across 5 years, with a median of $1.5 million in 2022.
• The largest YoY upside for Other Non-Current Liabilities was 16.12% in 2025 against a maximum downside of 89.94% in 2025.
• Dna X's Other Non-Current Liabilities stood at $1.4 million in 2022, then gained by 6.93% to $1.5 million in 2023, then rose by 11.19% to $1.7 million in 2024, then tumbled by 89.94% to $171000.0 in 2025, then jumped by 132.75% to $398000.0 in 2026.
• The last three Other Non-Current Liabilities figures came in at $398000.0 (Q1 2026), $171000.0 (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.